U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday.
Shares of Vanda Pharmaceuticals Inc. VNDA fell sharply in today's pre-market trading after the company rejected unsolicited takeover bids, citing undervaluation.
Vanda Pharmaceuticals shares dipped 6% to $5.96 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
- Trump Media & Technology Group Corp. DJT shares dipped 7.7% to $28.89 in pre-market trading. Trump Media & Technology Group shares dipped around 10% on Tuesday after the U.S. SEC declared effectiveness of the registration statement on Form S-1 related to the resale by certain securityholders of certain shares and warrants.
- Super Hi International Holding HDL shares fell 4.6% to $16.49 in pre-market trading. On Tuesday, Super Hi International posted a first-quarter loss of 1 cent per share on sales of $187.60 million.
- Ocugen, Inc. OCGN fell 4.4% to $1.32 in pre-market trading after gaining 3% on Tuesday.
- Qiagen N.V. QGEN fell 4.3% to $41.87 in pre-market trading after reporting quarterly results. On Monday, Qiagen announced at its Capital Markets Day a comprehensive strategy aimed at delivering solid and profitable growth through 2028. The company targets a 7% compound annual sales growth at constant exchange rates (CER) by 2028.
- STMicroelectronics N.V. STM declined 4.2% to $41.29 in pre-market trading. On Tuesday, Goldman Sachs analyst Alexander Duval upgraded STMicroelectronics from Sell to Neutral and raised the price target from $35.5 to $45.8.
- SolarEdge Technologies, Inc. SEDG shares slipped 3.2% to $35.87 in pre-market trading. SolarEdge Technologies announced the German launch of its high-power SolarEdge TerraMax™ Inverter combined with H1300 Power Optimizers.
- Arcutis Biotherapeutics Inc ARQT shares fell 3.1% to $7.90 in pre-market trading.
Now Read This: Hewlett Packard Enterprise, Accenture And 3 Stocks To Watch Heading Into Thursday
Don't forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.